• RenewingLives

    Using Advanced,
    Next-Generation Technology

  • ReunifyingFamilies

Clay Health Network assists healthcare providers in predicting how their patients will respond to medications based on their genetic profile in 20 therapeutic areas; more commonly known as personalized medicine and non-invasive cancer testing. We are headquartered in Cincinnati, Ohio and we are a nationally certified MBE organization. We are committed to providing the most advanced healthcare technology, focused on improving patient outcomes and lowering healthcare cost.

Our Story

Clay Health Network, established in 2016, came to fruition through our companies’ determination to provide access to high-quality healthcare technology, to all people and families nationwide. “Clay” is our namesake, “Health” is our motivation and “Network” consists of our capabilities and how we provide a premier product in personalized/precision medicine.

Our Belief

Our belief is innovation begins with viewing the world differently and having the ability to see around the corner, this is what our Pharmacogenomics product portfolio speaks to. By recognizing the problems in the world, we are determined to create helpful solutions that will improve patient treatment outcomes. We have dedicated team members and superior leadership who are passionate about making a difference and ensure the continued success of our clients.

Overview

Clay Health Network provides a comprehensive, personalized patient report applying superior non-invasive technology that gives healthcare providers a guided approach and dosage regimen for patients with a medical diagnosis in psychiatry, oncology, cardiology, pain management, urology, neurology, infectious disease and more. Applying Next Generation Sequencing (NGS) our Pharmacogenomics solution has 100% sensitivity and 100% specificity. Our validation is a direct comparison of data generated by Sanger sequencing.

Jointly Provided by New York Medical College and Touro College of Pharmacy.